Infection and drug resistance · 2026
Clinical Distribution and Antimicrobial Resistance Characteristics of Pseudomonas aeruginosa Infections in Otorhinolaryngology in Eastern China: A Single-Center Retrospective Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin Kaichun, Liu Yining, Lü Pan, Zhou Jian
Аннотация
BACKGROUND: Pseudomonas aeruginosa is a clinically important opportunistic pathogen in otorhinolaryngology, where chronic inflammation, impaired drainage, postoperative wounds, and device-associated biofilms may complicate treatment. Specialty-specific data linking anatomical distribution, multidrug resistance (MDR), and clinical outcomes remain limited in regional hospitals in China.
OBJECTIVE: To describe the clinical distribution and antimicrobial susceptibility profile of P. aeruginosa infections in otorhinolaryngology and to identify factors associated with MDR.
METHODS: This single-center retrospective cohort study included 112 consecutive patients with clinically adjudicated otorhinolaryngological infection and culture-confirmed P. aeruginosa at The First People's Hospital of Yongkang, Eastern China, from January to December 2024. MDR was defined as non-susceptibility to at least one agent in three or more antimicrobial categories. Group comparisons and multivariable logistic regression were performed.
RESULTS: The most common sites were the external ear canal/external ear (31.2%), middle ear/mastoid (25.0%), and nasal cavity/paranasal sinuses (21.4%). MDR was identified in 37 patients (33.0%). The highest susceptibility percentages were observed for colistin/polymyxin B (95.5%), amikacin (84.8%), and piperacillin-tazobactam (79.5%), whereas the highest resistance percentages were observed for aztreonam (32.1%), levofloxacin (27.7%), and ceftazidime (24.1%). Recent carbapenem exposure (adjusted odds ratio [aOR] 5.09, 95% confidence interval [CI] 1.22-21.19), postoperative indwelling devices/drainage (aOR 4.81, 95% CI 1.81-12.83), and hospital-acquired infection (aOR 2.52, 95% CI 1.02-6.23) were independently associated with MDR. MDR infections were associated with longer hospitalization, higher C-reactive protein levels, more antimicrobial regimen modifications, and lower clinical success.
CONCLUSION: This study provides specialty- and region-specific evidence that MDR P. aeruginosa is a substantial concern in otorhinolaryngological infections. In patients with recent carbapenem exposure, postoperative drainage or devices, or hospital-acquired infection, early culture acquisition, source control, and susceptibility-guided therapy are particularly important.
OBJECTIVE: To describe the clinical distribution and antimicrobial susceptibility profile of P. aeruginosa infections in otorhinolaryngology and to identify factors associated with MDR.
METHODS: This single-center retrospective cohort study included 112 consecutive patients with clinically adjudicated otorhinolaryngological infection and culture-confirmed P. aeruginosa at The First People's Hospital of Yongkang, Eastern China, from January to December 2024. MDR was defined as non-susceptibility to at least one agent in three or more antimicrobial categories. Group comparisons and multivariable logistic regression were performed.
RESULTS: The most common sites were the external ear canal/external ear (31.2%), middle ear/mastoid (25.0%), and nasal cavity/paranasal sinuses (21.4%). MDR was identified in 37 patients (33.0%). The highest susceptibility percentages were observed for colistin/polymyxin B (95.5%), amikacin (84.8%), and piperacillin-tazobactam (79.5%), whereas the highest resistance percentages were observed for aztreonam (32.1%), levofloxacin (27.7%), and ceftazidime (24.1%). Recent carbapenem exposure (adjusted odds ratio [aOR] 5.09, 95% confidence interval [CI] 1.22-21.19), postoperative indwelling devices/drainage (aOR 4.81, 95% CI 1.81-12.83), and hospital-acquired infection (aOR 2.52, 95% CI 1.02-6.23) were independently associated with MDR. MDR infections were associated with longer hospitalization, higher C-reactive protein levels, more antimicrobial regimen modifications, and lower clinical success.
CONCLUSION: This study provides specialty- and region-specific evidence that MDR P. aeruginosa is a substantial concern in otorhinolaryngological infections. In patients with recent carbapenem exposure, postoperative drainage or devices, or hospital-acquired infection, early culture acquisition, source control, and susceptibility-guided therapy are particularly important.